Institutional investors hold a majority ownership of THOR through the 96.10% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2014, these large investors purchased a net $335.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 900.00 shares of Thoratec Corp
STATE STREET GLOBAL ADVISORS IRE... Bought 389.00 shares of Thoratec Corp
CREDIT SUISSE AG Bought 300.00 shares of Thoratec Corp